gefitinib has been researched along with bibr 1532 in 2 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (bibr 1532) | Trials (bibr 1532) | Recent Studies (post-2010) (bibr 1532) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 62 | 0 | 47 |
| Protein | Taxonomy | gefitinib (IC50) | bibr 1532 (IC50) |
|---|---|---|---|
| Telomerase reverse transcriptase | Homo sapiens (human) | 1.6563 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 3.6 | |
| Sigma non-opioid intracellular receptor 1 | Cavia porcellus (domestic guinea pig) | 3.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
| Chen, X; Han, H; Han, M; He, C; Hu, J; Lin, F; Lin, H; Luo, Y; Qi, J; Wen, Z; Yang, M; Yang, R; Yang, Y; Yin, T | 1 |
2 other study(ies) available for gefitinib and bibr 1532
| Article | Year |
|---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Shikonin N-benzyl matrinic acid ester derivatives as novel telomerase inhibitors with potent activity against lung cancer cell lines.
Topics: Alkaloids; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Enzyme Inhibitors; G2 Phase Cell Cycle Checkpoints; Humans; Lung Neoplasms; Matrines; Molecular Docking Simulation; Naphthoquinones; Protein Binding; Quinolizines; Telomerase | 2022 |